Multicenter Study of Antimicrobial Susceptibility of Anaerobic Bacteria in Korea in 2012
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Yangsoon | - |
dc.contributor.author | Park, Yeon-Joon | - |
dc.contributor.author | Kim, Mi-Na | - |
dc.contributor.author | Uh, Young | - |
dc.contributor.author | Kim, Myung Sook | - |
dc.contributor.author | Lee, Kyungwon | - |
dc.date.accessioned | 2022-07-16T01:13:30Z | - |
dc.date.available | 2022-07-16T01:13:30Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 2234-3806 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/158296 | - |
dc.description.abstract | Background: Periodic monitoring of regional or institutional resistance trends of clinically important anaerobic bacteria is recommended, because the resistance of anaerobic pathogens to antimicrobial drugs and inappropriate therapy are associated with poor clinical outcomes. There has been no multicenter study of clinical anaerobic isolates in Korea. We aimed to determine the antimicrobial resistance patterns of clinically important anaerobes at multiple centers in Korea. Methods: A total of 268 non-duplicated clinical isolates of anaerobic bacteria were collected from four large medical centers in Korea in 2012. Antimicrobial susceptibility was tested by the agar dilution method according to the CLSI guidelines. The following antimicrobials were tested: piperacillin, piperacillin-tazobactam, cefoxitin, cefotetan, imipenem, meropenem, clindamycin, moxifloxacin, chloramphenicol, metronidazole, and tigecycline. Results: Organisms of the Bacteroides fragilis group were highly susceptible to piperacillin-tazobactam, imipenem, and meropenem, as their resistance rates to these three antimicrobials were lower than 6%. For B. fragilis group isolates and anaerobic gram-positive cocci, the resistance rates to moxifloxacin were 12-25% and 11-13%, respectively. Among B. fragilis group organisms, the resistance rates to tigecycline were 16-17%. Two isolates of Finegoldia magna were non-susceptible to chloramphenicol (minimum inhibitory concentrations of 16-32 mg/L). Resistance patterns were different among the different hospitals. Conclusions: Piperacillin-tazobactam, cefoxitin, and carbapemems are highly active β-lactam agents against most of the anaerobes. The resistance rates to moxifloxacin and tigecycline are slightly higher than those in the previous study. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC LABORATORY MEDICINE | - |
dc.title | Multicenter Study of Antimicrobial Susceptibility of Anaerobic Bacteria in Korea in 2012 | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Yangsoon | - |
dc.identifier.doi | 10.3343/alm.2015.35.5.479 | - |
dc.identifier.scopusid | 2-s2.0-84942237977 | - |
dc.identifier.wosid | 000358819400001 | - |
dc.identifier.bibliographicCitation | ANNALS OF LABORATORY MEDICINE, v.35, no.5, pp.479 - 486 | - |
dc.relation.isPartOf | ANNALS OF LABORATORY MEDICINE | - |
dc.citation.title | ANNALS OF LABORATORY MEDICINE | - |
dc.citation.volume | 35 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 479 | - |
dc.citation.endPage | 486 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002013442 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Medical Laboratory Technology | - |
dc.relation.journalWebOfScienceCategory | Medical Laboratory Technology | - |
dc.subject.keywordPlus | BACTEROIDES-FRAGILIS GROUP | - |
dc.subject.keywordPlus | IN-VITRO ACTIVITIES | - |
dc.subject.keywordPlus | ANTIBIOTIC SUSCEPTIBILITY | - |
dc.subject.keywordPlus | GROUP ORGANISMS | - |
dc.subject.keywordPlus | RESISTANCE | - |
dc.subject.keywordPlus | PATTERNS | - |
dc.subject.keywordPlus | SURVEILLANCE | - |
dc.subject.keywordPlus | MOXIFLOXACIN | - |
dc.subject.keywordPlus | TIGECYCLINE | - |
dc.subject.keywordPlus | INFECTIONS | - |
dc.subject.keywordAuthor | Anaerobe | - |
dc.subject.keywordAuthor | Multicenter | - |
dc.subject.keywordAuthor | Imipenem | - |
dc.subject.keywordAuthor | Moxifloxacin | - |
dc.subject.keywordAuthor | Tigecycline | - |
dc.identifier.url | https://www.annlabmed.org/journal/view.html?doi=10.3343/alm.2015.35.5.479 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.